New technology may help patients and providers assess changes in severity of Parkinson disease symptoms more objectively.
FDA Grants Regenerative Medicine Advanced Therapy Designation to Kyverna's KYV-101 for Refractory Stiff-Person Syndrome
Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease
Advances in Therapeutic Management for Parkinson Disease and Essential Tremor
Episode 116: Understanding Vorasidenib's Therapeutic Benefit on Neurocognition, Seizure Control in Diffuse Gliomas
NeuroVoices: David Shprecher, DO, MSci, FAAN, on Current and Future Directions in Biomarker Testing for Atypical Parkinsonism
New FNIH Initiative Looks to Expedite Parkinson Disease Diagnosis Through Validated Biomarkers